Lynda Charters

New option a potential treatment for patients diagnosed with dry eye disease.

While the 6-weekly regimen was less effective in improving the clinical activity score or exophthalmos than the higher dose regimen, it is an acceptable treatment choice for patients with marginal or lower clinical activity scores.

The investigative team wanted to provide physicians with reference guidelines to aid in the prevention and control of myopia.

Macular hole closure results from this novel treatment.

Study: AO retinal imaging has the potential to become a sensitive marker for disease.

Groundbreaking treatment for patients with bullous keratopathy approved in Japan.

Debate continues over the best way to apply the treatment option.

Nonpowder guns, like NERF guns, are causing an increase in ocular injuries in children.

A modified illuminated endolaser could be an efficient substitute for cryotherapy or indirect laser retinopexy during primary scleral buckling.

Bharti Nihalani-Gangwani, MD, from the Department of Ophthalmology, Children’s Hospital, and Deborah VanderVeen, MD, from the Department of Ophthalmology, Harvard Medical School, Boston, reported that 29% developed glaucoma in a large infant cohort and the risk factors at the American Society of Cataract and Refractive Surgery annual meeting.

Lucie Moore, BSc, in a presentation at the American Society of Cataract and Refractive Surgery annual meeting in San Diego, said the study focused on identifying factors that could put patients at a higher risk for developing dry eye disease.

Umida F. Mavlyanova, PhD, in a presentation at the American Society for Cataract and Refractive Surgery’s annual meeting in San Diego, detailed how patients diagnosed with end-stage chronic renal failure displayed deceased blood flow in the orbital artery, the central artery of the retina and the posterior short ciliary arteries.

Speaking at the American Society for Cataract and Refractive Surgery annual meeting in San Diego, Marcony Santhiago, MD, points out there are subtle differences in patients with keratoconus that was progressing compared with patients whose disease was stable and healthy control subjects.

Austin Fox, MD, discussed advancements in contact lens technology and use as part of a careful management strategy during Glaucoma Subspecialty Day at the American Society of Cataract and Refractive Surgery annual conference in San Diego.

In a presentation at the American Society for Cataract and Refractive Surgery annual meeting in San Diego, Erisa Yotsukura, MD, PhD, offered details of a study examining an IOL that transmits violet light and a second option that does not, and they believe this can affect differences in the choroidal thickness after cataract surgery.

Jason Bacharach, MD, presented results at the American Society of Cataract and Refractive Surgery annual meeting in San Diego, highlighting that a large phase 3 clinical trial demonstrated no relevant differences between the 2 formulations.

Preeya Gupta, MD, reported results of the trials at the American Society of Cataract and Refractive Surgery annual meeting in San Diego, showed that CSF-1, a low dose pilocarpine with an optimized formulation, demonstrated significant 2-line improvement from baseline.

In a presentation at the American Society for Cataract and Refractive Surgery annual meeting in San Diego, Ana Balbuena-Pareja, MSc, explained how cenegermin-bkbj ophthalmic solution 0.002% (Oxervate, Dompé) had a positive effect on corneal nerve regeneration and sensation in patients with neurotrophic keratitis.

Surgeon details training, experience with procedure that offers hope to patients.

Vitrectomy, lensectomy remain the primary surgical approaches for condition.

Efavirenz boosts cholesterol turnover in retina, brain.

Glaucoma specialists nationwide reported that glaucoma-related adverse events were common after cataract surgery in children.

Photobiomodulation is an emerging treatment for dry age-related macular degeneration (AMD).

Physician discusses clinical presentations, treatment options for 2 cases.

Surgeon expects more MIGS, less trabeculectomy.

Instead, vitamins C and E may actually be associated with a slightly increased risk of DED.

Body mass index (BMI), central obesity, and the metabolic syndrome may be deciding risk factors in glaucoma.

Therapies to target geographic atrophy are in sight.